| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |